Flexible, Intensive Insulin Therapy in Patients With Type 1 Diabetes

This study has been completed.
Diabetes Association Basel
University Hospital, Basel, Switzerland
Information provided by:
University of Lausanne Hospitals
ClinicalTrials.gov Identifier:
First received: December 28, 2007
Last updated: January 15, 2008
Last verified: December 2007
To prospectively evaluate the long term metabolic and psychological effects of flexible intensive insulin therapy (FIT) courses in an unselected population of type 1 diabetic patients at the University of Basel Hospital. We hypothesize that both metabolic control and psychological parameters will improve.

Condition Intervention
Diabetes Mellitus, Type 1
Behavioral: Flexible insulin therapy (FIT)

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Flexible, Intensive Insulin Management in Patients With Type 1 Diabetes and Changes in Metabolic Control, Quality of Life, Locus of Control and Diabetes Knowledge

Resource links provided by NLM:

Further study details as provided by University of Lausanne Hospitals:

Primary Outcome Measures:
  • Metabolic control (HbA1c, severe hypoglycemic events), psychological effects, diabetes knowledge [ Time Frame: Over 18 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Changes in insulin doses, changes in weight [ Time Frame: Over 18 months ] [ Designated as safety issue: No ]

Enrollment: 45
Study Start Date: April 2002
Study Completion Date: December 2007
Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Type 1 diabetes Behavioral: Flexible insulin therapy (FIT)
Flexible insulin therapy (FIT) courses consisting in 7 weekly ambulatory sessions lasting 90 minutes each


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients with type 1 diabetes followed at the Division of Endocrinology and Diabetology, University of Basel are strongly encouraged to attend the course 6 to 12 months after having been diagnosed. The population that participates in those FIT courses includes patients from the University of Basel Hospital, but also patients that are referred from out of hospital physicians/diabetologists.

Inclusion Criteria:

  • All patients participating in 5 consecutive FIT courses that began between April 2002 to April 2004

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00595569

University of Basel Hospital
Basel, Switzerland
Sponsors and Collaborators
University of Lausanne Hospitals
Diabetes Association Basel
University Hospital, Basel, Switzerland
Principal Investigator: Jardena J Puder, MD University of Lausanne, University of Basel
  More Information

No publications provided

Responsible Party: Dr. Jardena Puer, University of Lausanne Hospitals
ClinicalTrials.gov Identifier: NCT00595569     History of Changes
Other Study ID Numbers: 120/04 
Study First Received: December 28, 2007
Last Updated: January 15, 2008
Health Authority: Switzerland: Ethikkommission

Keywords provided by University of Lausanne Hospitals:
flexible insulin therapy
diabetes education
Weekly ambulatory sessions

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 1
Autoimmune Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Immune System Diseases
Metabolic Diseases
Insulin, Globin Zinc
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on February 07, 2016